Georgia shields Bayer from Roundup lawsuits becoming the second state to do so as MAHA report soon to be released, David Murray writes.

Bayer is fighting to keep the popular agricultural herbicide Roundup available for farmers in the U.S., but warned it could "reach the end of the road" and pull out of the market amid mounting challenges,

In a post-hoc analysis from the Phase III ARANOTE trial, new results show metastatic castration-sensitive prostate cancer patients treated with Nubeqa plus ADT experienced a clinically meaningful improvement in health-related quality of life and delayed pain progression.

Bayer CEO Bill Anderson takes the stage at the 2025 CNBC CEO Council Summit to talk to leaders about managing through uncertainty and tackling problems head-on.

German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea, giving it a potential edge over Roche's rival treatment Vabysmo.

Bayer A.G.'s stock is undervalued but faces risks with declining profits & regulatory pressures. Click for my updated look at BAYZF stock prospects post earnings.

Bayer shares jumped after the company reported better-than-expected sales and adjusted earnings for the first quarter, with cost-cutting and demand for kidney and cancer drugs boosting its pharmaceutical business.

Bayer CropScience shares gained more than 12% in the morning trades post Q4 Results, dividend announcement amid stock market crash. The Q4 results were announced after the market hours on Monday